What’s Vulnerable › Vulnerabilities
CVE-2024-10476
- Severity: high (CVSS 8.0 v3.1)
- Exploited in the wild: not listed in CISA KEV
- EPSS: 0.2% probability of exploitation in the next 30 days
- Public exploit or detection template: none known
- Published: 2024-12-17 · updated 2026-06-17
- Weakness: CWE-1392
Description
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
Affected products
- Becton Dickinson & Co BD BACTEC™ Blood Culture System: through 7.20
- Becton Dickinson & Co BD COR™ System: through 8.90
- Becton Dickinson & Co BD EpiCenter™ Microbiology Data Management System: through 7.45
- Becton Dickinson & Co BD MAX™ System: through 6.10
- Becton Dickinson & Co BD Phoenix™ M50 Automated Microbiology System: through 2.70
- Becton Dickinson & Co BD Synapsys™ Informatics Solution: through 6.10
References
Get alerted when CVE-2024-10476 or the next vulnerability affects your stack